(Monday, December 11, 2006) — Early Saturday morning the U.S. House of Representatives passed the Dietary Supplement and Nonprescription Drug Consumer Protection Act, S. 3546. This legislation had already passed in the Senate on December 6, and so it now goes to the White House where it is expected to be signed into law by President Bush.
This new law will require, effective in one year, that marketers of dietary supplements and OTC drugs inform FDA if they receive reports of serious adverse events associated with their products. AHPA has supported this law, as have other national trade associations as well as consumer groups.
"This bill was passed by unanimous consent in the Senate and by more than a 2 to 1 majority in the House," stated Michael McGuffin, AHPA’s president. "Such broad and bipartisan support for this important legislation is significant."
The bill was the last major action considered by the House in the 109th Congress, which adjourned only ten minutes after passage of the legislation. Because the bill had been placed on the suspension calendar, a two-thirds majority was needed, and was achieved by a vote of 203 to 98. The opposition votes consisted of 94 Republicans and 4 Democrats. This legislation was passed by unanimous consent in the Senate.
# # #
The American Herbal Products Association (AHPA) is a trade association representing the core of the botanical trade — comprised of the finest growers, processors, manufacturers and marketers of herbal products. AHPA’s mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbs are manufactured, labeled, and sold. Website: www.ahpa.org.